| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 8.054 | 21.803 | 20.028 | 3.899 | 6.099 | 9.279 | 13.347 | 25.231 | 27.350 |
| Total Income - EUR | - | 8.054 | 21.803 | 20.028 | 3.899 | 6.099 | 9.279 | 13.347 | 25.208 | 27.350 |
| Total Expenses - EUR | - | 23.289 | 20.427 | 16.376 | 15.974 | 15.385 | 12.661 | 8.853 | 20.070 | 17.115 |
| Gross Profit/Loss - EUR | - | -15.235 | 1.377 | 3.652 | -12.075 | -9.287 | -3.382 | 4.494 | 5.138 | 10.235 |
| Net Profit/Loss - EUR | - | -15.477 | 723 | 3.051 | -12.192 | -9.484 | -3.661 | 4.223 | 4.886 | 9.414 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Oftalmoinvest Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 88.211 | 70.807 | 53.888 | 37.527 | 21.789 | 9.000 | 3.869 | 0 | 0 |
| Current Assets | - | 153 | 1.009 | 863 | 31 | -2 | 39 | 5.159 | 13.536 | 12.776 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 985 | 860 | 0 | 0 | 0 | 1.710 | 198 | 197 |
| Cash | - | 153 | 24 | 4 | 31 | -2 | 39 | 3.448 | 13.338 | 12.579 |
| Shareholders Funds | - | -15.432 | -14.449 | -11.132 | -23.109 | -32.155 | -35.102 | -30.988 | -26.008 | -16.449 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 103.796 | 86.264 | 65.883 | 60.666 | 53.942 | 44.141 | 40.016 | 39.544 | 29.225 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oftalmoinvest Medical Srl